SA
IBB icon

SpiderRock Advisors’s iShares Biotechnology ETF IBB Stock Holding History

SpiderRock Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Hold
0
– -$9K – 210
2017
Q3 		– Hold
0
– – – 441
2017
Q2 		– Hold
0
– – – 243
2017
Q1 		– Hold
0
– – – 112

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

SpiderRock Advisors's IBB Position: Q3 2024 in Review

SpiderRock Advisors increased its iShares Biotechnology ETF (IBB) stake by 16% in Q3 2024, buying an estimated $36.9K and bringing the position to 1,827 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #752.

SpiderRock Advisors first reported a position in IBB in Q1 2024 and has held it in 3 quarters since. 893 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

  • SpiderRock Advisors held 1,827 shares of iShares Biotechnology ETF worth $266K as of Q3 2024.
  • SpiderRock Advisors bought 255 iShares Biotechnology ETF shares in Q3 2024, an estimated $36.9K.
  • iShares Biotechnology ETF made up ﹤0.01% of SpiderRock Advisors's portfolio in Q3 2024, its #752 holding.
  • SpiderRock Advisors first reported a position in iShares Biotechnology ETF in Q1 2024 and has held it in 3 quarters since.
  • 893 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.